期刊文献+

肾康注射液与肾康栓序贯治疗糖尿病肾病疗效观察 被引量:8

Therapeutic effects of sequential therapy of Shenkang injection combined with Shenkang suppository on diabetic nephropathy
下载PDF
导出
摘要 目的研究肾康注射液与肾康拴序贯治疗对于糖尿病肾病患者临床疗效影响,并对其机制分析。方法将120例诊断为糖尿病肾病患者随机分为对照组和治疗组,每组60例。对照组予西医常规基础治疗,治疗组在对照组治疗基础上予肾康注射液与肾康栓序贯治疗,时限为24周。治疗结束后观察2组患者尿微量白蛋白排泄率(UAER)、24 h尿蛋白定量(24 h UP)、肾肌酐清除率(Cr)、胱抑素C(Cys C)、血脂[总胆固醇(TC)、三酰甘油(TG)]及血糖[餐后2 h血糖(2 h PG)、空腹血糖(FBG)]比较。结果 2组治疗后血糖2 h PG、FPG、血脂(TC、TG)、24 h UP、Cr、UAER、Cys C水平均有所改善,且治疗组优于对照组,差异均有统计学意义;治疗组总有效率优于对照组(P <0. 05)。结论肾康注射液与肾康栓序贯治疗对于糖尿病肾病患者临床效果明显,临床值得推广。 Objective To observe the therapeutic effects of sequential therapy of Shenkang injection combined with Shenkang suppository on diabetic nephropathy,and to explore its action mechanism.Methods A total of 120 patients with diabetic nephropathy were randomly divided into two groups,with 60 patients in each group.The patients in control group were treated by conventional western medicine,however,the aptientsin treatment group,on the basis of control group,were treated by Shenkang injection combined with Shenkang suppository,with a treatment course of 24 weeks for both groups.The urinary microalbumin excretion rate(UAER),24h urine protein quantitation(24hUP),renal creatinine clearance rate(Cr),cystatin C(CysC),blood lipid indexes including TC and TG,and blood glucose indexes including 2hPG and FBG were observed and compared between the two groups.Results After treatment,the levels of 2hPG,FPG,TC,TG,24hUP,Cr,UAER,CysC were improved in both groups,moreover,which in treatment group were superior to those in control group.In addition the total effective rate in treatment group was superior to that in control group(P<0.05).Conclusion Therapeutic effects of sequential therapy of Shenkang injection combined with Shenkang suppository on diabetic nephropathy are quite significant,therefore,it is worthy of clinical promotion.
作者 李改仙 张虹 刘萍 伍华英 王皓 车秀英 贺晖英 LI Gaixian;ZHANG Hong;LIU Ping(Department of Endocrinology,General Hospital of Northern China Petroleum Administration Bureau,Hebei,Cangzhou 062552,China)
出处 《河北医药》 CAS 2018年第22期3410-3413,共4页 Hebei Medical Journal
基金 河北省中医药管理局科研计划项目(编号:2018517)
关键词 糖尿病肾病 肾康注射液 肾康栓 diabetic nephropathy Shenkang injection Shenkang suppository
  • 相关文献

参考文献14

二级参考文献75

共引文献297

同被引文献172

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部